insights_auto
Why is ZTS up 2,37%?
Dive Deeperchevron_right
ZTS:NYSE
Zoetis Inc
74,81 $
arrow_upward
+2,37%(+1,73) 1D
74,81 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 қаз., 16:03:16 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
73,04 $
High
74,85 $
Low
73,00 $
Mkt. cap
30,91 млрд
Avg. vol.
4,59 млн
Volume
2,91 млн
Dividend
2,83%
Quarterly dividend
0,53 $
Ex-dividend date
2026 ж. 20 шіл.
P/E ratio
12,31
52-wk high
148,30 $
52-wk low
68,77 $
EPS
6,08 $
Beta
0,74
Shares outstanding
413,22 млн
No. of employees
14 мың
Open
73,04 $
High
74,85 $
Low
73,00 $
Mkt. cap
30,91 млрд
Avg. vol.
4,59 млн
Volume
2,91 млн
Dividend
2,83%
Quarterly dividend
0,53 $
Ex-dividend date
2026 ж. 20 шіл.
P/E ratio
12,31
52-wk high
148,30 $
52-wk low
68,77 $
EPS
6,08 $
Beta
0,74
Shares outstanding
413,22 млн
No. of employees
14 мың
News stories
From web sources and news partners
Zacks
·
1 сағат бұрын
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance
·
2 сағат бұрын
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
Benzinga
·
6 сағат бұрын
10 Health Care Stocks Whale Activity In Today’s Session
Simply Wall Street
·
20 сағат бұрын
Zoetis (ZTS) Gets A Fresh Heartworm Boost While Fair Value Stays In Focus
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14,5 мың
Founded1952
HeadquartersParsippany-Troy Hills, Нью-Джерси, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitezoetis.com